相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intensive versus Conventional Glucose Control in Critically Ill Patients
S. Finfer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Randomized clinical trial of activated protein C for the treatment of acute lung injury
Kathleen D. Liu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial
Arthur Wheeler et al.
CRITICAL CARE MEDICINE (2008)
The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: A meta-analysis
Alan E. Jones et al.
CRITICAL CARE MEDICINE (2008)
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2008)
Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock
Simon Finfer et al.
INTENSIVE CARE MEDICINE (2008)
Systematic differences in treatment effect estimates between propensity score methods and logistic regression
Edwin P. Martens et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Informed consent and studies of a quality improvement program - Reply
Ricard Ferrer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain
Ricard Ferrer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studies
David Suarez et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Hydrocortisone therapy for patients with septic shock
Charles L. Sprung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis
Andre C. Kalil et al.
PLOS ONE (2008)
Sepsis incidence and outcome:: Contrasting the intensive care unit with the hospital ward
Andres Esteban et al.
CRITICAL CARE MEDICINE (2007)
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial
Simon Nadel et al.
LANCET (2007)
Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study
Salmaan Kanji et al.
INTENSIVE CARE MEDICINE (2007)
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: Analysis of efficacy and safety data in a large surgical cohort (vol 140, pg 726, 2005)
Didier Payen et al.
SURGERY (2007)
A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use
PC Austin et al.
STATISTICS IN MEDICINE (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Prescription of rh-APC differs substantially among western European countries
MJ Schultz et al.
INTENSIVE CARE MEDICINE (2006)
Sepsis in European intensive care units: Results of the SOAP study
JL Vincent et al.
CRITICAL CARE MEDICINE (2006)
Microvascular effects following treatment with polyethylene glycol-albumin in lipopolysaccharide-induced endotoxemia
N Hangai-Hoger et al.
CRITICAL CARE MEDICINE (2006)
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
E Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
J Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
D Annane et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
C Alberti et al.
INTENSIVE CARE MEDICINE (2002)
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
E Rivers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Intensive insulin therapy in critically ill patients.
G Van den Berghe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A comparison of observational studies and randomized, controlled trials.
K Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
RG Brower et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
